Enzymatic treatment of retinitis pigmentosa and relevant pharmaceutical composition in form of a kit

摘要

A pharmaceutical kit for the treatment of retinitis pigmentosa contains glutathione peroxidase, prolidase, glucose-6-phosphate dehydrogenase and optionally aldose reductase in aliquot parts. The enzymes are in quantities suitable for administering glutathione peroxidase at a concentration between 0.3 to 0.05 U.I. in 0.4ml pf physiological solution, prolidase at a concentration between 5 to 7 U.I. in 0.4ml pf physiological solution, glucose-6-phsophate dehydrogenase at a concentration between 7 to 9 U.I in 0.4ml pf physiological solution and aldose reductase at a concentration between 7 to 9 U.I in 0.4ml pf physiological solution each for three consecutive days, at monthly intervals, for three months, and for each eye.